AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 182 min read$CDLX

Gupta Amit sold $54K of CDLX

Gupta Amit (Chief Executive Officer) sold 13,461 shares of Cardlytics, Inc. (CDLX) at an average of $4.00 ($3.97–$4.03) across 2 trades over 2026-08-17 to 2026-08-18.

Original reporting
SEC EDGAR · Gupta Amit
Published Aug 18, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CDLX
Neutral
high confidence
Mentioned
$CDLX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CDLXNeutralLow
01

Why it matters

The disclosure provides a new datapoint on insider selling activity, but it does not include any new company performance, guidance, or deal information.

02

Market read

Traders may monitor for follow-on insider activity or corroborating company news, but this filing alone is unlikely to drive a major repricing.

03

What to watch

The filing does not state motivations, tax needs, or whether sales were planned; without follow-on insider buys or company news, trading impact is likely muted.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-18 after-hours

Background

The article reports an SEC Form 4 insider transaction by Cardlytics CEO Amit Gupta.

Company-level read

Ticker impact

$CDLXNeutralHigh confidence
Context

Cardlytics CEO Amit Gupta sold 13,461 shares in open-market trades at about $3.97 to $4.03, per a fresh SEC Form 4 filing.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small unless paired with other disclosures.

Evidence & confidence

The article is a primary-source Form 4 showing an open-market sale by the CEO, with no guidance, financial results, or regulatory/contract developments included.

Market effects

Sector

No clear sector read-through from a single insider open-market sale without additional context.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales can be routine liquidity events, especially without a 10b5-1 plan disclosed here, so the signal may be overstated.

Key entities

  • issuer
    Cardlytics, Inc.

    Subject of the Form 4 insider transaction; CEO Amit Gupta sold shares in open-market trades.

  • insider
    Amit Gupta

    Cardlytics CEO and director who executed the reported sales.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CDLX insider trading history →

Related articles

AUG 13
$CDLXMedAI 8/10

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics (CDLX) reported Q2 2026 results on an earnings call. Revenue was $36.9M, down 36% YoY, with billings $65.5M (-34%) and adjusted contribution $21.3M (-32%). Net loss was $14.9M. Q3 2026 guidance: billings $61M-$67M, revenue $34M-$39M, adjusted EBITDA $0M-$3M. Cash was $28M.

fool.com7 min
AUG 5
$CDLXMedAI 8/10

Cardlytics: Q2 Earnings Snapshot

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

local3news.com2 min
AUG 5
$CDLXMed

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Contribution of $21.3 million ◦ Net Loss of $(14.9) million

SEC EDGAR 8-K6 min
OCT 23
$RENTMed

Nexus Capital Management LP (Cohen Michael S, Flesh Daniel E.) purchased $2.2M of RENT (indirect holdings)

Nexus Capital Management LP purchased 632,922 indirectly-held shares of Rent the Runway, Inc. (RENT) at $3.55 ($2.25M total) on 2026-10-21. Filed jointly with Gateway Runway, LLC (Director), Gateway Runway Intermediate Holdings, Inc. (Director), NEXUS SPECIAL SITUATIONS III, L.P. (Director), NEXUS SPECIAL SITUATIONS III (CAYMAN), L.P. (Director), Nexus Special Situations GP III, LP (Director), Nexus Partners III, LLC (Director), Cohen Michael S (Director), Flesh Daniel E. (Director) and Giangiacomo Damian (Director).

SEC EDGAR1 min